SPDR MSCI EAFE Fossil Fuel Reserves Free ETF (EFAX)
| Assets | $241.46M |
| NAV | $81.85 |
| Expense Ratio | 0.20% |
| PE Ratio | 16.65 |
| Shares Out | 2.95M |
| Dividend (ttm) | $1.77 |
| Dividend Yield | 2.16% |
| Ex-Dividend Date | Jun 1, 2021 |
| 1-Year Return | +7.33% |
| Volume | 4,669 |
| Open | 85.93 |
| Previous Close | 83.96 |
| Day's Range | 81.56 - 82.48 |
| 52-Week Low | 74.68 |
| 52-Week High | 74.68 |
| Beta | 0.85 |
| Holdings | 820 |
| Inception Date | Oct 24, 2016 |
About EFAX
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the MSCI EAFE ex Fossil Fuels Index. Under normal market conditions, the fund generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index and in depositary receipts based on securities comprising the index. The index is designed to measure the performance of companies in the MSCI EAFE Index that are fossil fuel reserves free, as determined by the screening methodology used by the index.
Top 10 Holdings
14.09% of assets| Name | Symbol | Weight |
|---|---|---|
| Nestle S.A. | NESN.SW | 2.36% |
| ASML Holding NV | ASML.AS | 2.11% |
| Roche Holding Ltd | ROG.SW | 1.71% |
| LVMH Moet Hennessy Louis Vuitton SE | MC.PA | 1.43% |
| Toyota Motor Corp. | 7203.T | 1.23% |
| Novo Nordisk A/S Class B | NOVO B.CO | 1.15% |
| Novartis AG | NOVN.SW | 1.15% |
| AstraZeneca PLC | AZN.L | 1.11% |
| Sony Group Corporation | 6758.T | 0.97% |
| SAP SE | SAP.DE | 0.88% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Jun 1, 2021 | $1.10838 | Jun 8, 2021 |
| Dec 18, 2020 | $0.6611 | Dec 28, 2020 |
| Jun 1, 2020 | $0.65617 | Jun 8, 2020 |
| Dec 20, 2019 | $0.71266 | Dec 30, 2019 |
| Jun 3, 2019 | $1.24878 | Jun 10, 2019 |
| Dec 21, 2018 | $0.68557 | Dec 31, 2018 |
News
Hop on the ESG Bandwagon With These 3 ETFs
The environmental, social and governance (ESG) investing phenomenon has proven its mettle with strong performance amid the COVID-19 pandemic. That said, there's still room on a bandwagon that can only c...